Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study on Alternative Dosing Regimens in the Pharmacotherapy of Mild to Moderate Insomnia

NCT02139098 is registered in ClinicalTrials.gov with Philipps University Marburg as lead sponsor.

NCT NCT02139098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02139098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study on Alternative Dosing Regimens in the Pharmacotherapy of Mild to Moderate Insomnia
Lead sponsor
Philipps University Marburg
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2014
Completion date
November 30, 2017
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia